The Global Health Body Sounds Warning Over Acute Scarcity of Weight-Loss Jabs
Under one in 10 people that would benefit from weight-loss injections like Wegovy can access them, states the World Health Organization as it releases its first advice on the therapies.
With in excess of 1,000,000,000 individuals worldwide currently classified as obese, it is calling for increased and just availability to these injectable treatments.
Per forecasts, more than two billion are projected to be living with obesity by 2030 unless action is taken.
"The new guidelines recognises that excess weight is a long-term condition that can be addressed with holistic and ongoing treatment," remarked WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and logistical bottlenecks are major barriers to broad availability to the injections that can assist patients in reducing significant weight, notes the agency.
Weight-Loss Drug Supply Crisis
Even in the present most favorable case, the production of these medications could only cover around 100 million people – under 10% of eligible patients, according to the health organization.
The recommendation urges countries and companies to widen availability, via approaches including voluntary licensing.
A patent on a key compound – the core component of Novo Nordisk's Wegovy – is scheduled to end in several nations in 2026.
The Way Obesity Drugs Work
GLP-1 drugs replicate a natural hormone to reduce digestion speed, reduce hunger and increase satiety so people reduce food intake.
Patients commonly start to lose weight within a few weeks of starting on the weekly injections.
Evidence indicates patients may see weight return a year later of halting the medication, because their typical appetite come back.
Being above a healthy weight raises your risk for experiencing diseases, such as type 2 diabetes, cardiovascular issues, brain attack, and certain cancers.
Excess weight impacts people in all nations and was linked to millions of deaths worldwide in 2024, according to the WHO.
